ERD

2019-nCoV neutralization assay SOP, and dissemination of relevant plasmids.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Formulation characteristics and physicochemical evaluation of antigen-adjuvant combinations

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody resp...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Shared plasmid design

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

CoroNAb website for dissemination of results, and for fostering broader protocol, reagent, and result sharing by the sci...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Safety and immunogenicity data for each subunit /adjuvant combination. Selection of the best nCoV spike protein and adju...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian displ...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Scenarios will be developed for rollout of new antiviral therapy and a range of impacts will be examined in terms of imp...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Mathematical model will be released as open source R package. Model projections will be published online.

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Evasion of neutralising antibodies by omicron sublineage BA.2.75

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Virus evolution: The impact of antiviral therapies on evolution of the virus will be explored in terms of plausible impa...

Project: CoroNAb

Updated at: 29-04-2024

Show more information

Project acronym CoroNAb

Periodic Reporting for period 2 - CoroNAb (Nanobodies and antibodies against 2019-nCoV)

Project: CoroNAb

Updated at: 03-03-2023

Show more information

Project acronym CoroNAb

Resources

Selected filters:

2019-nCoV neutralization assay SOP, and dissemination of relevant plasmids.

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice

Formulation characteristics and physicochemical evaluation of antigen-adjuvant combinations

SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody resp...

Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study

Shared plasmid design

A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

CoroNAb website for dissemination of results, and for fostering broader protocol, reagent, and result sharing by the sci...

Safety and immunogenicity data for each subunit /adjuvant combination. Selection of the best nCoV spike protein and adju...

SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian displ...

Scenarios will be developed for rollout of new antiviral therapy and a range of impacts will be examined in terms of imp...

Mathematical model will be released as open source R package. Model projections will be published online.

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor...

Evasion of neutralising antibodies by omicron sublineage BA.2.75

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies

Virus evolution: The impact of antiviral therapies on evolution of the virus will be explored in terms of plausible impa...

Periodic Reporting for period 2 - CoroNAb (Nanobodies and antibodies against 2019-nCoV)